Pruritus in pregnancy and childhood--do we really consider all relevant differential diagnoses?

Elke Weisshaar1, Thomas L Diepgen, Thomas A Luger

  • 1Department of Social Medicine, Occupational and Environmental Dermatology, University Hospital of Heidelberg, Germany. elke.weisshaar@med.uni-heidelberg.de

Insights

Pruritus (itching) in pregnancy and childhood requires serious attention due to various causes. Tailored therapies are essential, considering safety for the fetus and appropriate drug dosages for children.

Area of Science:

  • Dermatology
  • Obstetrics
  • Pediatrics

Background:

  • Pruritus is a common dermatological symptom in pregnancy (18% of women) and childhood, often linked to atopic dermatitis (AD) or systemic diseases.
  • Pregnancy-specific conditions like polymorphic eruption of pregnancy (PEP) and Pemphigoid (Herpes) gestationis cause severe itching.
  • In children, pruritus can stem from dermatoses or, rarely, systemic conditions like renal or liver failure.

Purpose of the Study:

  • To highlight major etiologies of pruritus during pregnancy and childhood.
  • To outline key antipruritic therapies for these patient groups based on clinical experience.
  • To emphasize the need for interdisciplinary cooperation in managing pruritus in pregnant women and children.

Main Methods:

  • A two-center clinical experience review.
  • Analysis of major pruritus etiologies in pregnant women and children.
  • Discussion of established antipruritic treatment mainstays.

Main Results:

  • Pruritus in pregnancy and childhood has diverse causes requiring individualized treatment.
  • Therapeutic strategies must consider fetal safety and pediatric-specific drug administration.
  • Systemic treatments and phototherapy may be indicated but require careful application.

Conclusions:

  • Management of pruritus in pregnancy and childhood necessitates careful etiological diagnosis and tailored therapeutic approaches.
  • Physicians must consider unique patient factors, including fetal well-being and pediatric dosage adjustments.
  • Enhanced collaboration among dermatologists, gynecologists, pediatricians, and general practitioners is crucial for advancing knowledge and care.

Related Concept Videos

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.